The latest medication, Mounjaro, is generating considerable buzz within the medical community as a possible tool for controlling Adult-Onset Metabolic Disorder. Unlike some existing approaches, Mounjaro utilizes a dual mechanism , targeting both GLP-1 receptors and the GIP receptor, leading to better blood sugar management and, in some cases , i… Read More